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ABSTRACT 
 
 
It was previously established that MdmX, negative regulator or tumor suppressor p53, 
promotes genome stability and suppresses proliferation and tumorigenesis in a p53-independent 
manner. The purpose of this project was to determine whether protein Mdm2, another p53 
regulator previously shown to interact with MdmX, is required for the p53-independent role of 
MdmX in genome stabilization and suppression of cell transformation in vitro.  Triple knock-out 
(TKO) cells derived from the tumors of mice lacking p53, Mdm2, and MdmX were transfected 
with an MdmX expression plasmid. Compared to control cells, TKO cells ectopically expressing 
MdmX show decreased cell proliferation, a longer cell cycle, increased chromosome numbers 
and bipolar mitotic spindles, and decreased foci formation. Thus, MdmX, even in the absence of 
Mdm2, plays a role in genome stability and proliferation. This is crucial to consider in regards to 
potential cancer treatments aimed to suppress Mdm2 and/or MdmX in order to reactivate p53.  
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1.0 BACKGROUND 
 
1.1 Protein p53 
 
  p53 is a well-known and intensely studied protein in cancer biology, as it functions as a 
tumor suppressor. The p53 gene is the most commonly mutated gene in human cancers. In fact, 
50 percent of all human cancers contain an alteration in the p53 gene. Alternatively, cancers may 
also result from a mutation or deregulation of proteins that directly or indirectly interact with 
p53. In addition to the importance of p53 as a tumor suppressor, an increasing number of new 
roles for p53 have recently been reported, including the ability to regulate metabolism, fecundity, 
and various aspects of differentiation and development (Vousden and Prives, 2009).  
 Activity of p53 in normal cells is low. However, when the cell experiences DNA damage, 
p53 becomes active, initiating the expression of genes involved in DNA damage, cell cycle arrest 
or apoptosis (programmed cell death) (reviewed in Okorokov et al., 2006). p53 has a role in 
many non-stress situations as well, including the regulation of glycolysis and autophagy, cell 
survival, regulation of oxidative stress, cellular senescence and angiogenesis (Vousden and Lane, 
2007).  
p53 primarily functions as a transcription factor. It is activated by various stress signals 
including DNA damage, oncogene activation, telomere erosion, nutrient deprivation and 
hypoxia. p53 regulates the expression of an array of different genes that then mediate the p53 
response (Figure 1).  
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Figure 1: Overview of p53 Activation and Response. p53 is activated 
by many different situations, both stress and non-stress, and triggers 
pathways which result in various cellular responses (Vousden and Lane, 
2007). 
 
 
Upon DNA damage, protein kinases ATM and Chk2 phosphorylate p53, preventing its 
binding to Mdm2 (a negative regulator that promotes p53 degradation), thus increasing the 
cellular levels of p53 protein.  ATM and Chk2 participate in a phosphorylation cascade which 
induces cell cycle arrest at the G2 checkpoint. p53 prolongs the cell cycle arrest process by 
activating transcription of the gene coding for p21
Cip1
, a cyclin-dependent kinase inhibitor. This 
CKI binds to the Cdk-cyclin complex and inhibits the G1/S and G2/S transitions. Irreparably 
damaged cells have a high p53 activity, which activates proteins responsible for apoptosis (Voet 
et al., 2008). 
p53 may be activated by aberrant growth signals which cause the inappropriate activation 
of transcription factors. For example, Myc activates the transcription of the gene coding for 
p14
ARF
. This protein binds and inhibits a negative regulator of p53, Mdm2.  Therefore, p53 is 
stabilized, which triggers p53-dependent cell cycle arrest programs and apoptosis (Voet et al., 
2008). 
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Similarly, DNA-damaging chemotherapeutics, protein kinase inhibitors, and UV-
radiation can activate the protein kinase ATR, which phosphorylates p53 and reduces its affinity 
for Mdm2, resulting in cell cycle arrest and apoptosis (Voet et al., 2008).  
p53 also possesses transcriptionally-independent activities through direct interaction with 
other proteins. For example, p53 interacts with members of the BCL2 family of proteins (BAX) 
to elicit apoptosis (Vousden and Lane, 2007). 
The outcome of p53 activation, among other factors, depends on the extent of damage, 
and the duration of stress (Figure 2) (Vousden and Prives, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Tumor Suppressing Response of p53.  The p53 response 
involves the regulation of several target genes that mediate cell survival, 
proliferation, and death (Vousden and Prives, 2009). 
 
 
1.2 Mdm2 and MdmX – Negative Regulators of p53 
 
 During normal development, the inhibitory effect of p53 on cell growth must be held in 
check. Therefore, several molecules exist that act as negative regulators or “controllers” of p53. 
These include ubiquitin ligases that control p53 stability, kinases and acetylases that affect post-
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translational modification of the molecule, and transcriptional co-activators that modulate the 
transcriptional activity of p53 (Vousden and Lane, 2007). Most prominent negative regulators of 
p53 are the Mdm2 and MdmX proteins. Deletion of either Mdm2 or MdmX results in embryonic 
lethality, a result that is rescued by co-deletion of p53 (reviewed in Wade et al., 2010).   
 Mdm2 functions as an E3 ligase, and specifically ubiquinates p53, marking it for 
proteolytic degradation by the proteosome. In normal cells, p53 is regulated by a feedback loop 
where increased levels of p53 result in higher levels of Mdm2, which negatively regulates p53. 
Both Mdm2 and MdmX bind to the N-terminal activation domain of p53, promoting 
modifications that inhibit p53 transactivation function. Although structurally similar to Mdm2 
(Figure 3), the MdmX protein does not have a pronounced E3 ligase ability or effect on p53 
stability (Wade et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The Structure of Human Mdm2 and MdmX. (Wade et al., 2010). 
 
 
Mdm2 can form homo-oligomers, or it can hetero-oligomerize with MdmX, but MdmX 
alone is monomeric (Tanimura et al., 1999). Mdm2/MdmX heterodimer formation (Figure 4), is 
mediated by the C-terminal RING domain of both (Linke et al., 2008).  
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Figure 4: Diagram of Mdm2/MdmX Heterodimer. (Linke et al., 2008) 
  
Studies suggest that the Mdm2/MdmX hetero-oligomer is a more effective ligase for p53 
in vitro than Mdm2 alone (Linares et al., 2003), leading to the conclusion that MdmX contributes 
to p53 control by stabilizing the levels of Mdm2 (Linke et al., 2008). Following DNA damage, 
Mdm2 oligomers are phosphorylated and destabilized, leading to increased p53 levels. Mdm2 
then degrades itself and MdmX, removing Mdm2-Mdm2 and Mdm2-MdmX oligomers, resulting 
in maximum p53 accumulation. When DNA damage signaling ceases, kinase inhibition and 
phosphate activation remove the phosphorylated Mdm2 and MdmX which leads to their 
stabilization. The oligomers then continue to reduce p53 levels (Wade et al., 2010). 
 
1.3 p53-Independent Roles of MdmX 
 
 As a negative regulator of p53, over-expression of MdmX is potentially oncogenic, but 
surprisingly, MdmX was also found to have p53-independent roles in suppressing tumorigenesis 
and transformation (Matijasevic et al., 2008a). Mouse tumor cells double-null for p53 and 
MdmX show faster proliferation, increased genome stability, and an increased rate of 
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spontaneous tumorigenesis compared to p53-null cells/animals with intact MdmX (Matijasevic et 
al., 2008a). 
 While early passage p53-null and MdmX/p53-null cells show similar growth rates, the 
serial passaging of primary cells reveals an increase in growth rate of the MdmX/p53-null cells. 
Double-null cells are able to grow when plated at low densities and form much larger colonies 
than p53-null cells. A transformation assay shows that double-null cells form foci when allowed 
to grow to saturation density while p53-null cells do not (Matijasevic et al., 2008a). 
 MdmX not only suppresses cell proliferation, but helps maintain genome stability. 
Fluorescence Activated Cell Sorting (FACS) analysis comparing p53-null and double-null cells 
shows that the latter undergo a large reduction in ploidy. Double-null cells also undergo a 
reduction in chromosome number. Spindle formation in p53-null cells is mostly bipolar, with 
equal segregation of chromosomes, while double-null cell population shows an increased rate of 
multipolar spindles. Reintroduction of MdmX into double-null cells increases chromosome 
clustering and reduces multipolar spindle formation (Matijasevic et al., 2008b). 
 Mapping of the MdmX protein domain(s) responsible for the observed p53-independent 
functions using MdmX deletion mutants, is currently in progress in the Jones lab. 
Inhibition of the interaction of p53 with its negative regulators has been proposed as a 
potential cancer treatment. Yet the fact that MdmX also plays a role in the suppression of 
tumorigenesis and proliferation, and maintaining chromosome stability, shows that further 
knowledge is needed regarding the p53-independent MdmX roles to be sure the MdmX-
inhibiting treatments will not hinder the important characteristics of MdmX function 
(Matijasevic et al., unpublished). 
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1.4 Project Purpose 
 
 Proteins MdmX and Mdm2 have been shown to interact within the cell, and most 
previous studies have focused on the role of this interaction in the negative regulation of p53 
function and stability to increase tumorigenesis. Several p53-independent functions have also 
been described for MdmX, including MdmX-mediated decrease in tumorigenesis (Matijasevic et 
al., 2008a). It remains to be determined whether Mdm2 has a role in some of the p53-
independent MdmX functions described.  This project seeks to begin an investigation of whether 
MdmX retains its tumor-suppressing characteristics in an Mdm2/p53-independent manner. The 
goal of this project is to investigate in vitro the Mdm2 requirement for the p53-independent  
MdmX role in suppression of transformation and in genome stability.  
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2.0 EXPERIMENTAL DESIGN 
 
 
Tumor cells cultured from chest epithelium of Mdm2/MdmX/p53 triple knockout (TKO) 
mice will be stably transfected with an MdmX expression plasmid and co-transfected with a 
plasmid containing a puromycin-resistance gene. “Mock” control cells will be transfected with a 
plasmid containing the puromycin-resistance gene.  Transfectants will be selected on puromycin, 
then examined for MdmX expression by qPCR, and subjected to functional analysis, including 
cell proliferation, foci formation, cell cycle length, chromosome number, and spindle formation 
of each cell line. The phenotype of MdmX-transfected TKO cells will be compared to the 
previously obtained results with MdmX-transfected MdmX/p53-double knockouts (DKO) cells 
in order to determine the Mdm2 requirement for MdmX-mediated effects.  
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3.0 MATERIALS AND METHODS 
 
3.1 Cells 
 All experiments were performed with epithelial tumor cells isolated from mice deleted 
for p53, Mdm2, and MdmX (TKO, triple knockout). Cells were grown on DMEM media 
supplemented with 10% FBS and 10% antibiotic as attached culture. 
 
3.2 Plasmid Purification, Digestion, and Linearization 
Plasmid DNA was isolated and purified using a Qiagen Maxiprep kit from 300 µL of 
bacterial culture. Plasmid identity was confirmed by digestion with restriction enzymes PVU, 
Xho and HindIII (Figure 5). According to the plasmid map, the double digest for the MdmX 
expression plasmids would be expected to produce bands at approximately 1.6 kb and 5 kb, 
which was confirmed by the digest gel.  
 
 
 
  
Figure 5:  Digestion of MdmX Expression Plasmids.  Plasmid 
DNA was digested with PVU and HindIII, then electrophoresed 
on an agarose gel.  Positive clones containing the MdmX cDNA 
show bands at 1.6 kb and 5 kb. 
 
 
3.3 TKO Transfections 
 
 Cells were plated in a 6-well format and grown to 70% confluency in media with no 
antibiotics. The DNA to be transfected (MDMX expression construct and/or puromycin 
expression construct pBABE-Puro at a 6:1 molar ratio; or GFP) was diluted in 50 uL of DMEM 
without serum, and mixed. An appropriate amount of Lipofectamine-2000 (Invitrogen) was 
diluted in DMEM and incubated for 5 minutes at room temperature. The DNA and 
Lipofectamine were mixed and allowed to incubate at room temperature for 20 minutes. 100 uL 
of the mixture was added to each well and rocked gently. Cells were incubated at 37ºC. The 
media was changed 6 hours later. The cells were re-plated 24 hours after transfection, and 
selected for puromycin resistance.  
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3.4 qRT-PCR 
 
 RNA Extraction 
 Cells were grown in a 6-well plate format and collected with 0.5 mL of Trizol. Then 0.2 
mL of CHCl3 was added, and the cells were incubated for 3 minutes at room temperature, then 
shook vigorously for 15 seconds. The tubes were centrifuged for 15 minutes at 12,000 X g at 4ºC 
and the clear supernatant was transferred to a fresh tube. The tubes were combined with 0.5 mL 
of isopropanol, incubated for 10 minutes at room temperature, then centrifuged for 10 minutes at 
12,000 X g at 4ºC. The supernatant was removed, and 1.0 mL of 75% ethanol in 
diethylpyrocarbonate (DEPC) water was added to the pellet and inverted several times. The tubes 
were centrifuged for 5 minutes at 7.5 X g at 4ºC, the ethanol was removed, and the pellet was 
dried for 5 minutes. 50 uL of DEPC water was added to the pellets which were then left on ice 
for 30 minutes. The RNA was then quantified by spectrophotometry.  
 
cDNA synthesis 
The following mixture was prepared for each RNA sample: 5 ug RNA, 5 uL random 
hexamers (50 ng/uL), 1 uL 10 mM dNTP mix, and DEPC water to bring the volume to 10 uL. 
The samples were placed in a Themocycler for incubation for 5 minutes at 65ºC, then cooled for 
one minute. The following mixture was prepared (enough for each sample): 2 uL 10X RT buffer, 
4 uL 25 mM MgCl2, 2 uL 0.1 M DTT, and 1 uL RNaseOUT Recombinant Ribonuclease 
Inhibitor. 9 uL of this mixture was added to each sample, mixed, and incubated for 2 minutes at 
25ºC. 1 uL (50 units) of SuperScript II RT was added to each tube. The tubes were placed in a 
Thermocycler and incubated at 25ºC for 10 minutes, 42ºC for 50 minutes, 70ºC for 15 minutes, 
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then chilled. 1 uL of RNase H was added to each tube and then incubated for 20 minutes at 37ºC. 
All reagents were from Invitrogen. 
 
qRT-PCR 
The master mix for PCR tubes was prepared for each well: 12.1 uL GoTag gPCR Master 
Mix (Promega), 10.5 uL H2O, 0.2 uL forward primer, and 0.2 uL reverse primer.  23 uL of the 
master mix was added to each well in the PCR plate. 2 uL of each cDNA sample was added to 
each well containing the master mix. The PCR tubes were capped and placed into the PCR 
machine. 
 
3.5 Functional Analysis 
 
Transfected cells were assayed for the effects of MdmX expression on cell proliferation, 
foci formation, cell cycle length, chromosome number, and spindle formation as follows: 
 
Proliferation Assay 
 Cells were plated at .01X10
6
 cells per well in a six-well plate format. Each well was fed 
every three days with fresh media. Each day, two wells per sample were harvested with recorded 
volumes of trypsin and media, then were counted in triplicate. The number of cells per plate was 
calculated for each well per day.  
 
Chromosome Spreads 
 Cells were grown to 1 X 10
6
 in 150cm2 dishes. Pre-warmed media was added with 
colcemid solution (10 ug Gibco 15210-040) at a concentration of 0.02 ug/mL. The cells were 
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incubated at 37ºC for 90 minutes. The cells were harvested with trypsin, counted and 
centrifuged. The media and PBS used to harvest the cells were centrifuged to keep dislodged 
cells and added to the harvested cells. 10 mL of 37ºC hypotonic solution (0.075 M KCl) was 
added to the cells, which were then incubated at 37ºC for 18 minutes. A few drops of fixative 
(3:1 methanol : acetic acid) was added.  Cells were collected by centrifugation, mixed with 1 mL 
of fixative added drop by drop while agitating and incubated on ice for 30 minutes. The cells 
were centrifuged at 500 RPM for 5 minutes and 1 mL of fixative was added. To prepare mitotic 
spreads, about 20 uL of the fixed swollen cells was dropped onto a glass microscope slide run 
quickly through a flame and placed on a 60ºC warmer. The cell density of the slides was checked 
and the last step repeated to determine the appropriate final volume of fixative. The slides were 
stained with DAPI (1 ug/mL) in PBS (200 uL DAPI/100 mL PBS) for 30-60 seconds, and then 
rinsed with PBS. Several drops of Permount solution were added to the slides along with a cover 
slip. After one hour the slides were examined with a 40x oil immersion microscope.  
 
Mitotic Spreads 
 Cells were grown in 6-well plates on top of coverslips. Coverslips were removed with 
cells from media, dipped briefly in pre-warmed 37°C PBS, and fixed in -20°C pre-cooled 
methanol for 5 minutes. Cells were removed and placed in room temperature PBS for 5 minutes. 
The PBS was removed, and PBS with 3% BSA and 0.5% Tween 20 was added at room 
temperature for one hour. The primary antibody (Sigma mouse monoclonal anti-alpha tubulin 
and Sigma rabbit polyclonal anti-gamma tubulin) were diluted 1:4000 in PBS, 3% BSA, 0.5% 
Tween 20. Coverslips were removed and placed cell-side down on 100 uL drop of primary 
antibody, and then incubated overnight at 4°C. The coverslips were washed 3 times with PBS, 
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1% BSA, 0.5% Tween 20. The secondary antibodies (molecular probes goat anti-mouse ALEXA 
488 and molecular probes goat anti-rabbit ALEXA594) were diluted 1:1000 in PBS, 3% BSA, 
0.5% Tween 20. Coverslips were placed cell-side down on 100 uL drop of secondary antibody 
and incubated for 1 hour at 37 °C. The coverslips were washed 3 times with PBS, 1% BSA, 
0.5% Tween 20 and incubated on a 100 uL drop of Hoescht 33258 solution (made 10 ug/mL in 
PBS) for 5-15 minutes, and then washed for 10 minutes in PBS. The coverslips were placed cell-
side down on 7 uL mounting media (50:50 PBS:Glycerol) on a slide and sealed with clear nail 
polish. The slides were examined with a 100x oil immersion microscope. 
 
Soft Agar Assay (Foci Formation) 
 A bottom layer of 1% agar in 1xDMEM/FBS was solidified in 60mm plates. Cells were 
grown, harvested and counted. Then 13,000 cells were added to the 45dC soft agar (0.5% final) 
in DMEM/FBS and poured on the top of the bottom layer. The plates were placed into the 37°C 
incubator. Once the upper layer was solid, 0.75 ml of 1xDMEM, 10% FBS were added to all 
plates. The cells were fed with 1mL of 1xDMEM, 10% FBS twice per week. Cells were fixed 
with methanol and stained with crystal violet to evaluate foci formation. 
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4.0 RESULTS 
 
The purpose of this project is to determine whether protein Mdm2, previously shown to 
interact with MdmX, is required for the p53-independent promotion of genome stability and 
suppression of cell transformation by MdmX.  Triple knockout cells were derived from tumors 
of mice lacking three proteins: p53, Mdm2, and MdmX.  MdmX was then ectopically expressed 
in these cells by transformation with an MdmX expression plasmid.  Transfectants were screened 
by RT-PCR for the expression of MdmX. The cells were then assayed for various transformation 
phenotypes, including cell proliferation, cell cycle length, chromosome number, spindle 
formation, and foci formation. The results of these functional assays were compared to those of 
cells transfected with a mock plasmid.  
 
4.1 Transfection Efficiency and Cell Viability 
 
To test the transfection efficiency and possible cytotoxicity of the transfection reagent, 
cells were transiently transfected (without selection) with an expression plasmid encoding Green 
Fluorescent Protein (GFP) and a plasmid encoding MdmX, using two different transfection 
reagents (X-treme GENE Roche and Lipofectamine 2000, Invitrogen). Human Embryonic 
Kidney (HEK) cells were used as a positive control. Transfection efficiency was determined as a 
ratio of GFP-positive cells to total cells from the fractions of 6-well plate images (Figure 6 and 
Table 1). Cell survival was determined by counting total cell number of harvested cells in the 
control and transfected wells. The data showed that the cells with the lower transfection rate had 
a higher survival, while cells with higher transfection rate showed a lower survival, suggesting 
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that the MdmX over-expression can affect cell survival and that cells cannot tolerate high levels 
of MdmX.  
  
 
 
Figure 6:  Transfection Efficiency and Cell Survival.   Two different 
transfection reagents (R or L) were used to co-transfect cells with MdmX 
and GFP plasmids.  The percent of GPF-positive cells and the percent 
surviving cells are shown. 
 
Table 1: Transfection Reagent Toxicity 
Reagent Conc. 
(µL/well) 
Transfection Reagent + 
MdmX 
Transfection Reagent 
Only 
  30 hours 25 hours 44 hours 
  GFP-pos. survival survival % survival % 
No TR    100 100 
Roche 10 7.5% 72% 87 83 
Roche 15   83 58 
Lipo 10 20% 32% 100 83 
Lipo 15   93 83 
 
 The results show that mouse tumor cells transfected at lower efficiency than HEK cells 
and that Lipofectamine is more efficient and a less toxic tranfection reagent under the 
experimental conditions. 
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4.2 RT-PCR 
 
An expression plasmid containing the MdmX cDNA and/or puromycin resistance was 
stably transfected into TKO tumor cells using Lipofectamine. The transfected cells were selected 
for puromycin resistance. Positive transfectants were screened for levels of MdmX mRNA using 
qRT-PCR (Figure 7).  Cells transfected with the plasmid encoding MdmX showed much higher 
levels of MdmX than parental TKO cells or cells transfected with the control plasmid.   
 
 
  
  
Figure 7:  qRT-PCR of MdmX mRNA Levels in TKO Transfectants.  
Cells transfected with the plasmid encoding MdmX showed much 
higher levels of MdmX than parental TKO cells or cells transfected 
with the control plasmid.   
 
4.3 Effect of MdmX on Cell Proliferation  
 
A cell proliferation assay was performed on TKO cells transfected with mock plasmid or 
with full length MdmX (Figure 8). When plated at an initial low density, both cell lines seemed 
to behave similarly, but at higher densities over a 7-day period, the proliferation rate of cells 
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transfected with MdmX was significantly slower than the mock control, suggesting that MdmX 
plays a role in suppressing cell proliferation in an Mdm2-independent manner, and that the 
plating density affects the cell growth. 
  
 
 
 
Figure 8:  Effects of MdmX Expression on Cell Proliferation.   Cells 
derived from tumors of mice deficient for p53, Mdm2, and MdmX (triple 
knockouts, TKO) were transfected with plasmid not encoding MdmX 
(mock) or encoding MdmX (FL). 
 
 
4.4 Effect of MdmX on Cell Cycle Length
 
In collaboration with Sluder’s lab at UMMS, TKO cells transfected with MdmX and 
control cells were subjected to time lapse videomicroscopy to determine the cell cycle length at 
the single cell level. The cell cycle length was calculated as the time from anaphase of one cell to 
the anaphase of the daughter cell (Figure 9). The data showed that cells ectopically expressing 
MdmX have a significantly longer cell cycle length compared to cells without MdmX.   The 
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cycle lengths of 12.94 and 14.2 might not seem like a large difference, but an unpaired t test 
proves that the difference in time is extremely statistically significant. This increase in cell cycle 
length likely explains the slower proliferation of the cells ectopically expressing MdmX, and 
again confirms that MdmX plays a role in suppressing cell proliferation in an Mdm2-
independent manner. 
 
 
 
Figure 9:  Effects of MdmX Expression on Cell Cycle Length.   
Tumor cells derived from mice deficient for p53, Mdm2, and MdmX 
were transfected with plasmid not encoding MdmX (mock) or encoding 
MdmX (FL), and their cell cycle length measured by time lapse video 
microscopy. 
 
4.5 Effect of MdmX on Chromosome Number 
 
Chromosome spreads were prepared for mock and MdmX transfected cell clones, stained 
with DAPI, and observed under a fluorescent microscope (Figure 10).  Chromosome number in 
at least sixty cells per cell line were determined. The results are expressed as the percent of cells 
with a larger than triploid genome (more than 60 chromosomes). Cells transfected with an 
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MdmX plasmid have almost twice as many cells with a larger than triploid genome, suggesting 
that the MdmX suppression of chromosome loss is not Mdm2-dependent. 
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Figure 10:  Effects of MdmX Expression on Chromosome Number.   
Chromosome spreads were prepared from TKO cells ectopically 
expressing MdmX and for control cells. Cells that lack MdmX show a 
decreased chromosome number (top picture: chromosome <60; bottom 
picture: chromosomes >60). 
 
4.6 Effect of MdmX on Mitotic Spindles 
 
MdmX was previously found to have a p53-independent role in maintaining genome 
stability, partly in terms of promoting bipolar spindle formation during mitosis in p53-deficient 
cells. To determine the requirement for Mdm2 in spindle polarity in MdmX-transfected TKO 
cells, mock and clones were stained with alpha-tubulin for microtubules, gamma-tubulin for 
centrosomes, and DAPI for DNA, and were observed under a fluorescent microscope (Figure 
11).  The upper panel shows examples of the various shapes of spindles that were observed.  
Normal spindle shape is bipolar with two centrosomes (left column), however normal cells can 
also contain some spindles with amplified centrosomes that were still bipolar (third column). 
Some had amplified centrosomes and were multipolar (second column).  Another broad category 
included asymmetrical spindles that were elongated and were often seen in pairs or tandems.   
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The spindles observed were separated into one of three categories: bipolar, multipolar, or 
asymmetric. When comparing cells that will presumably divide correctly to those that will not, 
both biopolar spindles and spindles with amplified centrosomes that are still bipolar were placed 
together. This category was then compared to both obviously multipolar spindles and spindles 
that were considered multipolar and/or asymmetric (grouped as “irregular”). This is because it is 
unknown for sure whether the asymmetric spindles will divide incorrectly. The middle panels 
show the number of multipolar or “irregular” spindles for mock and MdmX clones calculated as 
a percent of all spindles observed. Cells ectopically expressing MdmX showed a decreased 
number of abnormal spindles. This suggests that MdmX plays a role in promoting bipolar 
spindle formation even in the absence of Mdm2. 
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          Figure 11:  Effects of MdmX Expression on Irregular Spindle Formation.   
                      Cells were stained with alpha-tubulin for microtubules, gamma-tubulin for  
                      centrosomes, and DAPI for DNA, and were observed under a fluorescent microscope.  
                      Cells ectopically expressing MdmX show a reduction in irregular spindles.  
 
 
 
4.8 Effect of MdmX on Cell Transformation in vitro (Soft Agar Analysis) 
 
A soft agar assay determines the ability of cells for anchorage-independent growth, 
manifested as foci formation in soft agar.  A soft agar assay was conducted using the mock and 
MdmX transfected TKO cell clones. MdmX expressing clones showed a great reduction in both 
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size and number of foci compared to the parental or mock transfected cells in two separate 
experiments (Figure 12). This shows that similar to DKO cells, MdmX suppresses foci 
formation in TKO cells, suggesting that Mdm2 is not required for MdmX to suppress cell 
transformation in vitro. 
  
 
 
 
Figure 12:  Effects of MdmX Expression on Foci Formation (Soft 
Agar Assay).   Cells derived from triple knockout p53, Mdm2, and 
MdmX-deficient mice were transfected with a control plasmid or 
encoding MdmX and their foci formation was assayed in soft agar. Cells 
ectopically expressing MdmX show a lower rate of foci formation (red 
and blue indicate two different experiments). 
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5.0 DISCUSSION 
 
5.1 Conclusions 
 
The purpose of this project was to determine whether protein Mdm2, previously shown to 
interact with MdmX, is required for the p53-independent promotion of genome stability and 
suppression of cell transformation by MdmX.  TKO cells were derived from tumors of mice 
lacking p53, Mdm2, and MdmX.  MdmX was then ectopically expressed in these cells by 
transformation with an MdmX expression plasmid. MdmX expression was confirmed by qRT-
PCR. 
 The cells were assayed for various transformation phenotypes. Cells ectopically 
expressing MdmX that were plated at a known low number over seven days showed slower 
growth when compared to control cells. This difference in growth rates is confirmed by the 
analysis of cell cycle length by video microscopy, showing that cell expressing MdmX have a 
significantly longer cell cycle when compared to control cells.  Similar to p53-null cells, 
p53/Mdm2-null cells maintained an increased chromosome number. Cells expressing MdmX had 
a higher occurrence of bipolar spindle formation, while mock cells frequently produced  
multipolar or asymmetric spindles. Finally, cells ectopically expressing MdmX showed lower 
foci formation in soft agar than did control cells. 
These data strongly parallel data obtained through similar studies. These were done with 
double-knockout cells that were p53/MdmX-null. Serial passage of primary cells revealed an 
increase in growth rate of the MdmX/p53-null cells when compared to p53-null cells. Double-
null were able to form foci when allowed to grow to saturation density while p53-null cells do 
not (Matijasevic et al., 2008a).  Double-null cells also underwent a reduction in chromosome 
number. Spindle formation in p53-null cells was mostly bipolar, with equal segregation of 
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chromosomes, while the double-null cell population shows an increased rate of multipolar 
spindles. Reintroduction of MdmX into double-null cells increased chromosome clustering and 
reduced multipolar spindle formation (Matijasevic et al., 2008b). 
 The conclusions of the DKO and TKO experiments regarding the role of MdmX strongly 
parallel each other. Despite the fact that MdmX and Mdm2 often form heterodimers, the role of 
MmdX in genome stability and cell transformation seems to remain unaltered whether in the 
presence or absence of Mdm2. This provides strong evidence that MdmX retains its important 
role in promoting genome stability and suppressing cell transformation in the absence of both 
p53 and Mdm2 in vitro.  
 
5.2 Experimental Setbacks 
The Jones’ lab had also begun mapping of the MdmX protein domain(s) responsible for 
the observed p53-independent functions using MdmX deletion mutants. So far, the results 
suggest that the role of MdmX in suppressing proliferation is separated from its role in genome 
stability, with the RING domain regulating proliferation, and the RanBP Zn-finger domain 
regulating genome stability.  The original goal of this MQP project was not only to examine the 
effect of MdmX on TKO cells, but also to examine whether the RING and RAN domain retain 
their respective roles in an Mdm2-null background. Deletion constructs were transfected into 
TKO cells and tested alongside the full length MdmX transfectants. However, no solid 
conclusions could be drawn from any of the assays using the deletion constructs. Whether this 
was due to an unsuccessful transfection or inconsistency of assay preparation is unknown.  
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FACS analysis was also performed on the full length MdmX transfectants as well as 
deletion construct transfections. Despite multiple attempts with different transfections, all cell 
lines appeared to have identical ploidy. The reason for this is again unknown. 
It was attempted in earnest to achieve the detection of MdmX through Western Blots 
using an antibody to probe for MdmX, yet none were successful. HEK cells, as a positive 
control, showed high transfection efficiency and high levels of MdmX expression through qPCR, 
and was also able to be detected through Western Blot. Yet with MdmX-transfected TKO cells, 
despite having confirmed levels of MdmX through qPCR, even endogenous levels of MdmX 
could not be detected. Despite different antibodies and conditions, the detection of MdmX was 
on a whole unsuccessful. 
  
5.3 Future Experiments 
 These experiments have only begun the long process of fully understanding the 
relationship between p53, Mdm2 and MdmX in tumor suppression. In the continuation of this 
reasearch, it would be beneficial to attempt further transfections with the deletion mutants in an 
attempt to achieve the expected results from functional analysis. Here one can discover whether 
the roles of the MdmX domains behave similarly in the absence of Mdm2, or whether Mdm2 
might actually be required for their respective effects on the cell.  
 Most importantly, these conclusions are strong when it comes to in vitro conditions, but 
there are many factors that can affect the interactions studied here when they are introduced into 
a living organism. These in vivo studies should be done using mice as test subjects as a 
continuation of the previous DKO experiments (as described in Matijasevic et al., 2008b). Only 
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in vivo studies will confirm the relationship of MdmX and Mmd2 that was concluded by this 
project.  
 
5.4 Medical Importance 
Due to the fact that it is a negative regulator of p53, the suppression of MdmX and Mdm2 
has been proposed as a potential cancer therapy in several ways; first, by reducing the cellular 
levels of MdmX; second, by developing small molecules that relieve the MdmX-dependent 
inhibition of p53, which would restore p53 function; and third, by using existing Mdm2 
antagonists with agents that sensitize cells to p53-dependent apoptosis (Wade et al., 2009).  
Yet it has also been previously shown that MdmX plays a role in the suppression of 
tumorigenesis and genome stability, suggesting that further knowledge is needed regarding the 
p53-independent MdmX roles to be sure the MdmX-inhibiting treatments will not hinder the 
important characteristics of MdmX function (Matijasevic et al., unpublished). This project 
provides even more insight into the relationship between p53, Mdm2, and MdmX, so that the 
effects of the removal of either Mdm2 or MdmX can be taken into consideration when 
contemplating these potential cancer therapies.  
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